ESC 365 - Cryoablation as first-line treatment for persistent atrial fibrillation.

Open Access

Cryoablation as first-line treatment for persistent atrial fibrillation.

Session: Cardiac rhythm management 2022: from atrial fibrillation to heart failure

Topic: Device Treatment

Speaker: Doctor J. McCready (London, GB)

Sponsored by Medtronic

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor James McCready

London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

5 more presentations in this session

Welcome and introduction.

Speaker: Doctor F. Arribas (Madrid, ES)

Device infections and the antibacterial envelope: implementing the WRAP-IT trial in clinical practice.

Speaker: Doctor D. Wright (Liverpool, GB)

Cardiac resynchronization: from patient selection to optimal therapy delivery.

Speaker: Associate Professor R. Borgquist (Copenhagen, DK)

Management of heart failure patients using device based risk stratification.

Speaker: Professor M. Oliveira (Lisbon, PT)

Summary and conclusions.

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)

Access the full session

Cardiac rhythm management 2022: from atrial fibrillation to heart failure

Speakers: Doctor J. McCready, Doctor F. Arribas, Doctor D. Wright, Associate Professor R. Borgquist, Professor M. Oliveira...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources